Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher Chanan-Khan

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
Psychosomatics|May 4, 2020
Impact of Depression and Anxiety on Opioid Use in Hospitalized Hematopoietic Cell Transplantation RecipientsMadiha Iqbal, Aaron Spaulding, Shehzad Niazi, et al.
Chemmedchem|August 7, 2018
Synthesis, Computational Docking Study, and Biological Evaluation of a Library of Heterocyclic Curcuminoids with Remarkable Antitumor ActivityKenneth K Laali, William J Greves, Angela T Zwarycz, et al.
Annals of Hematology|January 13, 2021
Utilization of radiation therapy in multiple myeloma: trends and changes in practiceSikander Ailawadhi, Ryan Frank, Meghna Ailawadhi, et al.
Anti-Cancer Drugs|August 16, 2019
Monoclonal antibody utilization characteristics in patients with multiple myelomaSikander Ailawadhi, Taimur Sher, Abdel-Ghani Azzouqa, et al.
Cancer|January 24, 2018
Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparitiesSikander Ailawadhi, Ryan D Frank, Mayank Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2019
Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic LeukemiaAlak Manna, Sonikpreet Aulakh, Prachi Jani, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 5, 2019
Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic MinoritiesSikander Ailawadhi, Abdel-Ghani Azzouqa, David Hodge, et al.
JCO Oncology Practice|February 13, 2020
Timeliness of Initial Therapy in Multiple Myeloma: Trends and Factors Affecting Patient CareVivek Kumar, Muhamad Alhaj-Moustafa, Leyla Bojanini, et al.
Blood Cancer Journal|October 2, 2019
Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemiaVivek Kumar, Sikander Ailawadhi, Leyla Bojanini, et al.
Leukemia & Lymphoma|January 4, 2018
Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS studyPaula Cramer, Graeme Fraser, Rodrigo Santucci-Silva, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Psychosomatics|May 4, 2020
Impact of Depression and Anxiety on Opioid Use in Hospitalized Hematopoietic Cell Transplantation RecipientsMadiha Iqbal, Aaron Spaulding, Shehzad Niazi, et al.
Chemmedchem|August 7, 2018
Synthesis, Computational Docking Study, and Biological Evaluation of a Library of Heterocyclic Curcuminoids with Remarkable Antitumor ActivityKenneth K Laali, William J Greves, Angela T Zwarycz, et al.
Annals of Hematology|January 13, 2021
Utilization of radiation therapy in multiple myeloma: trends and changes in practiceSikander Ailawadhi, Ryan Frank, Meghna Ailawadhi, et al.
Anti-Cancer Drugs|August 16, 2019
Monoclonal antibody utilization characteristics in patients with multiple myelomaSikander Ailawadhi, Taimur Sher, Abdel-Ghani Azzouqa, et al.
Cancer|January 24, 2018
Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparitiesSikander Ailawadhi, Ryan D Frank, Mayank Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2019
Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic LeukemiaAlak Manna, Sonikpreet Aulakh, Prachi Jani, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 5, 2019
Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic MinoritiesSikander Ailawadhi, Abdel-Ghani Azzouqa, David Hodge, et al.
JCO Oncology Practice|February 13, 2020
Timeliness of Initial Therapy in Multiple Myeloma: Trends and Factors Affecting Patient CareVivek Kumar, Muhamad Alhaj-Moustafa, Leyla Bojanini, et al.
Blood Cancer Journal|October 2, 2019
Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemiaVivek Kumar, Sikander Ailawadhi, Leyla Bojanini, et al.
Leukemia & Lymphoma|January 4, 2018
Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS studyPaula Cramer, Graeme Fraser, Rodrigo Santucci-Silva, et al.
Pageof 11